These findings suggest that in Stage IV melanoma, immune and tumor cells preferentially localize within CD74- and MIF-enriched neighborhoods, while iNOS-associated neighborhoods see a reduced presence of CTLs, T cells, and tumor cells. The gene discussed is CD74; the disease is melanoma.